Algert Global LLC Molecular Templates, Inc. Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$7.82 - $12.44 $549,018 - $873,375	-70,207 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.33 - $14.05 $497,316 - $748,907	-53,303 Reduced 43.16%	70,207 $886,000
Q4 2020 Feb 12, 2021	SELL	$8.48 - $12.23 $15,772 - $22,747	-1,860 Reduced 1.48%	123,510 $1.16 Million
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $720,598 - $1.04 Million	72,132 Added 135.49%	125,370 $1.37 Million
Q2 2020 Aug 12, 2020	BUY	$12.28 - $17.63 $653,762 - $938,585	53,238 New	53,238 $734,000

Q1 2020 May 13, 2020	SELL	$11.31 - $18.26 $445,681 - $719,553	-39,406 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$6.44 - $14.21 $130,410 - $287,752	20,250 Added 105.71%	39,406 $551,000
Q2 2019 Aug 14, 2019	BUY	$5.83 - $8.42 $111,679 - $161,293	19,156 New	19,156 $160,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $65.4M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.